LS Investment Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,694
Closed -$81K 1052
2020
Q2
$81K Hold
1,694
0.01% 1050
2020
Q1
$72K Hold
1,694
0.01% 1009
2019
Q4
$100K Sell
1,694
-3,203
-65% -$174K 0.01% 1113
2019
Q3
$250K Buy
4,897
+128
+3% +$6.1K 0.01% 692
2019
Q2
$202K Sell
4,769
-192
-4% -$8.34K 0.01% 774
2019
Q1
$245K Buy
4,961
+11
+0.2% +$498 0.02% 702
2018
Q4
$214K Buy
4,950
+715
+17% +$35.7K 0.01% 717
2018
Q3
$240K Sell
4,235
-689
-14% -$36.3K 0.01% 765
2018
Q2
$248K Buy
4,924
+104
+2% +$5.42K 0.02% 777
2018
Q1
$240K Sell
4,820
-763
-14% -$35.9K 0.01% 773
2017
Q4
$229K Buy
5,583
+2,385
+75% +$83.5K 0.01% 826
2017
Q3
$95K Sell
3,198
-2,954
-48% -$90.2K 0.01% 1169
2017
Q2
$204K Buy
6,152
+995
+19% +$31.3K 0.01% 884
2017
Q1
$153K Sell
5,157
-196
-4% -$5.35K 0.01% 957
2016
Q4
$133K Buy
+5,353
New +$122K 0.01% 953

Other funds holding GMED

LS Investment Advisors's GMED Position: Q3 2020 in Review

LS Investment Advisors sold out of Globus Medical (GMED) in Q3 2020, closing a stake of 1,694 shares — an estimated $81K sold.

LS Investment Advisors first reported a position in GMED in Q4 2016 and held it in 15 quarters. The position peaked at $250K in Q3 2019. 344 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

  • LS Investment Advisors reported no remaining Globus Medical position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 1,694 Globus Medical shares in Q3 2020, an estimated $81K.
  • LS Investment Advisors first reported a position in Globus Medical in Q4 2016 and held it in 15 quarters.
  • LS Investment Advisors's Globus Medical position peaked at $250K in Q3 2019.
  • 344 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.